OSUR

OraSure Technologies, Inc. develops and manufactures rapid diagnostic tests and sample management solutions for various medical conditions. Its product portfolio includes tests for COVID-19, HIV, HCV, syphilis, sickle cell disease, and Ebola, as well as self-collection devices for stabilizing DNA and RNA from multiple sample types. The company operates in the United States, Canada, and the United Kingdom, with a focus on point-of-care diagnostics and molecular sample management.